Evidence map›Paper›PMID 38595246›Full record

ArticleBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences2024

[A unicenter real-world study of the correlation factors for complete clinical response in idiopathic inflammatory myopathies].

Zhanhong Lai, Jiachen Li, Zelin Yun, Yonggang Zhang, Hao Zhang, Xiaoyan Xing, Miao Shao, Yuebo Jin, Naidi Wang, Yimin Li and 2 more

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC
In one paragraph

Article in Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. [Immunological characteristics of patients with anti-synthetase syndrome overlap with rheumatoid arthritis].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Zhanhong LaiDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.
Jiachen LiDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.
Zelin YunDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.
Yonggang ZhangDepartment of Rheumatology and Immunology, Baoding First Hospital, Baoding 071000, Hebei, China.
Hao ZhangDepartment of Rheumatology and Immunology, Dalian Municipal Central Hospital, Dalian 116089, Liaoning, China.
Xiaoyan XingDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.
Miao ShaoDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.
Yuebo JinDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.
Naidi WangDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.
Yimin LiDepartment of Rheumatology and Immunology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Yuhui LiDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.
Zhanguo LiDepartment of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.
Peking University · CNPeking University People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the correlation factors of complete clinical response in idiopathic inflammatory myopathies (IIMs) patients receiving conventional treatment.

methodsPatients diagnosed with IIMs hospitalized in Peking University People's Hospital from January 2000 to June 2023 were included. The correlation factors of complete clinical response to conventional treatment were identified by analyzing the clinical characteristics, laboratory features, peripheral blood lymphocytes, immunological indicators, and therapeutic drugs.

resultsAmong the 635 patients included, 518 patients finished the follow-up, with an average time of 36.8 months. The total complete clinical response rate of IIMs was 50.0% (259/518). The complete clinical response rate of dermatomyositis (DM), anti-synthetase syndrome (ASS) and immune-mediated necrotizing myopathy (IMNM) were 53.5%, 48.9% and 39.0%, respectively. Fever (

conclusionThe total complete clinical response rate of IIMs is low, especially for IMNM subtype. More effective intervention should be administered to patients with ILD, elevated AST, elevated serum ferritin or decreased count of CD4

Indexed as

Autoimmune DiseasesHyperferritinemiaLung Diseases, InterstitialMyositisAutoantibodiesHumansPathologic Complete ResponseRetrospective StudiesAutoantibodiesAutoantibodiesClinical responseIdiopathic inflammatory myopathiesInterstitial lung diseaseRisk factors

Identifiers

PMID38595246
PMCPMC11004955
OpenAlexW4394740044

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.